Tech Company Financing Transactions
Azaya Therapeutics Funding Round
Texas Emerging Technology Fund and private investors participated in a $1 million funding round for Azaya Therapeutics. The round was announced on 9/29/2009.
Transaction Overview
Company Name
Announced On
9/29/2009
Transaction Type
Venture Equity
Amount
$1,045,000
Round
Undisclosed
Investors
Proceeds Purpose
This investment by the State of Texas followed an extensive due diligence process and we thank SATAI for helping us with the process. Today's announcement represents an important step in validating and commercializing our technology platform.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
12500 Network Blvd. 207
San Antonio, TX 78249
USA
San Antonio, TX 78249
USA
Phone
Website
Email Address
Overview
Azaya Therapeutics, Inc. is an emerging specialty pharmaceutical company with a novel drug delivery system. Its proprietary Protein Stabilized Nanoparticle (PSN) technology platform addresses the significant problems associated with delivery of water insoluble drugs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
John Kerr
Chief Executive Officer
Michael Dwyer
Browse more venture capital transactions:
Prev: 9/29/2009: Blue Noodle venture capital transaction
Next: 9/29/2009: eCommLink venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We record funding rounds that are announced publicly. VC investment data records on this site are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs